CareDx, Inc. v. Natera, Inc.
Case Number:
1:19-cv-00662
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 07, 2023
Natera, CareDx Both Blocked From Making False Ad Claims
A Delaware federal judge on Monday granted a stipulated agreement barring medical test making companies Natera and CareDx from using false marketing to sell their kidney transplant rejection tests, finding that both companies violated the Lanham Act at different times.
-
July 17, 2023
Judge Nixes Damages From $45M Natera False Ad Verdict
A Delaware federal judge on Monday threw out a $44.9 million damages award against medical test maker Natera Inc., although he otherwise upheld the bulk of a jury's finding that Natera falsely advertised its transplant rejection test as superior to rival CareDx's product.
-
March 15, 2022
Jury Hits Natera With $45M Verdict In CareDx False Ad Suit
A Delaware federal jury on Monday awarded CareDx $44.9 million after finding that rival medical test company Natera Inc. falsely advertised its kidney transplant rejection test as superior to CareDx's competing product, but found that CareDx engaged in false advertising as well.
-
March 03, 2022
IP Forecast: Tech Giants' Voice Tech Row Heads To Fed. Circ.
Microsoft and Google are heading to the Federal Circuit next week to challenge rulings by the Patent Trial and Appeal Board that partially upheld voice technology patents that are connected to Apple’s Siri brand and now owned by a Wi-LAN subsidiary. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
October 21, 2021
IP Forecast: Google Lyrics Battle To Play Out At 2nd Circ.
The Second Circuit will consider next week whether copyright law preempts claims by lyrics website Genius that Google misappropriated content for the tech giant's search results. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.